A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints

被引:10
|
作者
Natarajan, R
Turnbull, BW
Slate, EH
Clark, LC
机构
[1] CORNELL UNIV,SCH OPERAT RES & IND ENGN,ITHACA,NY 14853
[2] UNIV ARIZONA,CTR CANC,TUCSON,AZ
基金
美国国家卫生研究院;
关键词
clinical trials; power; sample size; multiple treatments; factorial design; treatment lag; multiple comparisons; Fisher's LSD; stratification; Monte Carlo method;
D O I
10.1016/0169-2607(96)01717-8
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
This paper presents a computer program for use in the design of long-term clinical trials with multiple treatment arms in which the primary outcome variables are censored survival times, The treatment arms may be structured as a one-way or multi-way factorial design. It is assumed that patients are entered and randomized to a treatment arm during an accrual period. The patients are then followed for a fixed period during which there may be dropouts. Various distributional assumptions can be used to model the survival times. These include an option in which there is an effect of treatment duly after a lag or delay time. The program then computes the power of various statistical tests of hypotheses concerning treatment differences, interactions and trends. The power computations are ''exact'' in that they use the Monte Carlo method to obtain Type I and II error probabilities. However the program also outputs the normal approximations for comparison, although they are typically not accurate in these situations. Fisher's LSD method is used to adjust for the multiple comparisons. By comparing the power for various sets of design parameters, such as sample size, numbers of factor levels, patient accrual rate, and length of follow-up, an appropriate design can be constructed. Two examples are provided. The first is a simple one-way layout with multiple treatment arms; the second a two-way factorial design for a proposed large scale cancer chemoprevention trial.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 50 条
  • [31] Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials
    Lin, Jianchang
    Bunn, Veronica
    CONTEMPORARY CLINICAL TRIALS, 2017, 54 : 48 - 59
  • [32] Power and Sample Size Calculations for the Restricted Mean Time Analysis of Prioritized Composite Endpoints
    Mao, Lu
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (03): : 540 - 548
  • [33] Power and Sample Size Determination in Clinical Trials with Multiple Primary Continuous Correlated Endpoints
    de Micheaux, Pierre Lafaye
    Liquet, Benoit
    Marque, Sebastien
    Riou, Jeremie
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (02) : 378 - 397
  • [34] Sample size calculations for paediatric multiple sclerosis clinical trials using clinical relapse and MRI lesion endpoints
    Verhey, L. H.
    Signori, A.
    Arnold, D. L.
    Bar-Or, A.
    Sadovnick, A. D.
    Marrie, R. A.
    Banwell, B.
    Sormani, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 92 - 92
  • [35] A convenient formula for sample size calculations in clinical trials with multiple co-primary continuous endpoints
    Sugimoto, Tomoyuki
    Sozu, Takashi
    Hamasaki, Toshimitsu
    PHARMACEUTICAL STATISTICS, 2012, 11 (02) : 118 - 128
  • [36] Power/sample size calculations for assessing correlates of risk in clinical efficacy trials
    Gilbert, Peter B.
    Janes, Holly E.
    Huang, Yunda
    STATISTICS IN MEDICINE, 2016, 35 (21) : 3745 - 3759
  • [37] EXEMPLARY DATA - SAMPLE-SIZE AND POWER IN THE DESIGN OF EVENT TIME CLINICAL-TRIALS
    GOLDMAN, AI
    HILLMAN, DW
    CONTROLLED CLINICAL TRIALS, 1992, 13 (04): : 256 - 271
  • [38] MSurvPow: a FORTRAN program to calculate the sample size and power for cluster-randomized clinical trials with survival outcomes
    Gao, F
    Manatunga, AK
    Chen, SD
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2005, 78 (01) : 61 - 67
  • [39] Sample size determination in complex clinical trials comparing more than two groups for survival endpoints
    Ahnn, S
    Anderson, SJ
    STATISTICS IN MEDICINE, 1998, 17 (21) : 2525 - 2534
  • [40] Reconsideration of sample size and power calculation for overall survival in cancer clinical trials
    Jung, Inkyung
    Ko, Hee Jung
    Rha, Sun Young
    Nam, Chung Mo
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 12 : 90 - 91